Long-term safety and tolerability of eptinezumab in patients with chronic migraine: a 2-year, open-label, phase 3 trial

por Kudrow, David, Cady, Roger K., Allan, Brent, Pederson, Susan M., Hirman, Joe, Mehta, Lahar R., Schaeffler, Barbara A.
Publicado 2021

Prolonged-release fampridine and walking and balance in MS: randomised controlled MOBILE trial

por Hupperts, Raymond, Lycke, Jan, Short, Christine, Gasperini, Claudio, McNeill, Manjit, Medori, Rossella, Tofil-Kaluza, Agata, Hovenden, Maria, Mehta, Lahar R, Elkins, Jacob
Publicado 2016